Gianni Tognoni

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial

J. Michael Gaziano, Carlos Brotons, Rosa Coppolecchia et al. · The Lancet · 2018 · 849 citations · Full text

Thrombosis, Hypertension, Cardiovascular Disease +10

Caffeine disposition after oral doses

Maurizio Bonati, Roberto Latini, Ferruccio Galletti et al. · Clinical Pharmacology & Therapeutics · 1982 · 352 citations

Benzodiazepines

Cesario Bellantuono, Valerio Reggi, Gianni Tognoni et al. · Drugs · 1980 · 172 citations

Interspecies Comparison of In Vivo Caffeine Pharmacokinetics in Man, Monkey, Rabbit, Rat and Mouse

Maurizio Bonati, Roberto Latini, Gianni Tognoni et al. · Drug Metabolism Reviews · 1984 · 170 citations

Pharmacokinetic Modeling, Pharmacological Study, Medicine +11

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin

Roberto Latini, Gianni Tognoni, Aldo P. Maggioni et al. · Journal of the American College of Cardiology · 2000 · 166 citations

Thrombosis, Hypertension, Cardiovascular Disease +11